Interleukin-1, neuroinflammation, and Alzheimer's disease

Neurobiology of Aging

Volumn 22, Issue 6, 2001, Pages 903-908

  Mrak, Robert E ^a   Griffin, W Sue T ^b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

A plaques; A precursor protein; Aging; Alzheimer's disease; Astrocytes; Down's syndrome; Head trauma; IL 1; Microglia; Neuritic plaques; S100B

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; INTERLEUKIN 1; PROTEIN; PROTEIN PRECURSOR; PROTEIN S100B;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN; CELL ACTIVATION; CELLULAR IMMUNITY; CLINICAL TRIAL; DISEASE ASSOCIATION; DNA POLYMORPHISM; DYSTROPHY; HOMOZYGOTE; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; NERVE FIBER GROWTH; NERVOUS SYSTEM INFLAMMATION; NEURITE; NEUROTOXICITY; ONSET AGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR;

ALZHEIMER DISEASE; ANIMALS; BRAIN CHEMISTRY; HUMANS; INFLAMMATION; INTERLEUKIN-1; NEURONS; POLYMORPHISM, GENETIC;

EID: 0035690976     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00287-1     Document Type: Article

References (68)

1. A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study
2. Do non-steroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study
3. Interleukin-1: A gene expression system regulated at multiple levels
4. Microglial activation by Alzheimer amyloid precursor protein, and modulation by apolipoprotein E
5. S100β stimulates calcium fluxes in glial, and neuronal cells
6. Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies
7. Inverse association of anti-inflammatory treatments, and Alzheimer's disease: Initial results of a co-twin control study
8. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory, and histamine H2 blocking drugs
9. Cholinergic agonists, and interleukin 1 regulate processing, and secretion of the Alzheimer β/A4 amyloid protein precursor
10. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1
11. Novel genetic association of an IL-1B gene variation at +3953 with interleukin-1β protein production, and psoriasis
12. Biological basis for IL-1 in disease
13. Association of an interleukin 1 α polymorphism with Alzheimer's disease
14. Inflammation in EAE: Role of chemokine/cytokine expression by resident, and infiltrating cells
15. Prevalence of Alzheimer plaques in AIDS
16. Expression of amyloid precursor protein mRNAs in endothelial, neuronal, and glial cells: Modulation by interleukin 1
17. Leptin, and the regulation of body weight in mammals
18. Association of Aβ 40-positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease, and in non-demented aged individuals
19. Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells
20. Microglial interleukin-1 α expression in human head injury: Correlations with neuronal, and neuritic β-amyloid precursor protein expression
21. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution
22. Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression
23. Brain interleukin 1, and S-100 immunoreactivity are elevated in Down syndrome, and Alzheimer disease
24. Association of early-onset Alzheimer's disease with an interleukin-1 α gene polymorphism
25. Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1, and tumor necrosis factor (TNF) but not interleukin-6
26. Brain macrophages synthesize interleukin-1, and interleukin-1 mRNAs in vitro
27. S100β stimulates inducible nitric oxide synthase activity, and mRNA levels in rat cortical astrocytes
28. Gene polymorphisms of interleukins 1, and 10 in infectious, and autoimmune diseases
29. Interleukin 1(IL-1)β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy
30. Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices
31. Genetic variations in cytokine expression: A risk factor for severity of adult periodontitis
32. Sleep. A physiologic role for IL-1β, and TNF-α
33. Cytokine production by human fetal microglia, and astrocytes. Differential induction by lipopolysaccharide and IL1β
34. S100β induction of the pro-inflammatory cytokine interleukin-6 in neurons: Implications for Alzheimer pathogenesis
35. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity, and mRNA expression
36. 1-antichymotrypsin, and interleukin-1 plasma levels increases Alzheimer's disease risk
37. Ibuprofen suppresses plaque pathology, and inflammation in a mouse model for Alzheimer's disease
38. Role of microglia in senile plaque formation
39. Senile plaques in temporal lobe epilepsy
40. S100 as a neurotrophic factor
41. A genetic association between juvenile rheumatoid arthritis, and a novel interleukin-1 α polymorphism
42. Genetic association studies of interleukin-1 (I-1A, and IL-1B), and interleukin-1 receptor antagonist genes, and the risk of Alzheimer's disease
43. Head trauma as a risk factor for Alzheimer's disease: A collaborative reanalysis of case control studies. EURODEM Risk Factors Research Group
44. The role of chronic self-propagating glial responses in neurodegeneration: Implications for long-lived survivors of human immunodeficiency virus
45. Glial cytokines in Alzheimer's disease: Review, and pathogenic implications
46. Glial cytokines in neurodegenerative conditions
47. β-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1β and 1 α and fibroblast growth factors
48. Association of interleukin-1 gene polymorphisms with Alzheimer's disease
49. Influence of IL-1β gene polymorphisms on age-at-onset of sporadic Parkinson's disease
50. A Taq 1 polymorphism in the human interleukin-1β (IL-1β) correlates with IL-1β secretion in vitro
51. Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease
52. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease
53. Biologic activities of IL-1, and its role in human disease
54. Interleukin 1 in the brain: Biology, pathology, and therapeutic target
55. A neuromodulatory role of interleukin-1β in the hippocampus
56. Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients
57. In vitro production of IL6, IL1β, and TNF α by human embryonic microglial, and neural cells
58. Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy: Association with interleukin-1α immunoreactivity
59. Distribution of IL-1-immunoreactive microglia in cerebral cortical layers: Implications for neuritic plaque formation in Alzheimer's disease
60. In vivo, and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis
61. Microglial interleukin-1α expression in brain regions in Alzheimer's disease: Correlation with neuritic plaque distribution
62. Enlarged, and phagocytic, but not primed, IL-1α-immunoreactive microglia increase with age in normal human brain
63. Progressive neuronal injury associated with amyloid plaque formation in Alzheimer's disease
64. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1α protein in gingival crevicular fluid of teeth with severe periodontal disease
65. Glial cytokines as neuropathogenic factors in HIV infection: Pathogenic similarities to Alzheimer's disease
66. Potential mechanisms of interleukin-1 involvement in cerebral ischemia
67. "Inflammatory" cytokines: Neuromodulators in normal brain?
68. Occurrence of neuropathological changes, and dementia of Alzheimer's disease in Down's syndrome